{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:08:44Z","timestamp":1788883724390,"version":"build-2803163510"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004099","name":"National League Against Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cytogfr.2026.07.004","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:16:07Z","timestamp":1784330167000},"page":"82-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The multifaceted roles of IL-1\u03b2 in Alzheimer\u2019s disease: From pathogenic amplifier to neuroimmune modulator"],"prefix":"10.1016","volume":"91","author":[{"given":"Dominika","family":"Pilat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e9vin","family":"Baranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6649-2712","authenticated-orcid":false,"given":"Santiago","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2026.07.004_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer\u2019s Disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","article-title":"The genetics of Alzheimer disease: back to the future","volume":"68","author":"Bertram","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","article-title":"An overview of APP processing enzymes and products","volume":"12","author":"Chow","year":"2010","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","article-title":"Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior","volume":"192","author":"Selkoe","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib9","article-title":"A\u03b2 oligomers peak in early stages of Alzheimer\u2019s disease preceding tau pathology","volume":"16","author":"Bl\u00f6meke","year":"2024","journal-title":"Alzheimers Dement. (Amst."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Sig Transduct. Target. Ther."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib12","article-title":"Distinct factors drive the progression of tau pathology in Alzheimer\u2019s disease","author":"Luo","year":"2025","journal-title":"Fundam. Res."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib13","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"European Alzheimer\u2019s Disease Initiative (EADI)","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Alzheimer Disease Genetics Consortium (ADGC)","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib17","first-page":"1003","article-title":"Neuroinflammation Induces Neurodegeneration","volume":"1","author":"Kempuraj","year":"2016","journal-title":"J. Neurol. Neurosurg. Spine"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fimmu.2020.00456","article-title":"A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer\u2019s disease","volume":"11","author":"Hampel","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib19","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib21","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI90606","article-title":"Microglia in Alzheimer\u2019s disease","volume":"127","author":"Sarlus","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/imcb.12301","article-title":"The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer\u2019s disease","volume":"98","author":"Webers","year":"2020","journal-title":"Immunol. Cell. Biol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer\u2019s disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib24","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/brain\/awt171","article-title":"Dissecting phenotypic traits linked to human resilience to Alzheimer\u2019s pathology","volume":"136","author":"Perez-Nievas","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1750-3639.2008.00188.x","article-title":"Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer\u2019s disease","volume":"19","author":"Sokolova","year":"2009","journal-title":"Brain Pathol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib26","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal antiinflammatory drugs and the risk of Alzheimer\u2019s disease","volume":"345","author":"B.A. in t\u2019 Veld","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0197-4580(00)00148-2","article-title":"Key issues in Alzheimer\u2019s disease inflammation","volume":"21","author":"Cooper","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement. (N. Y)"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30487-6","article-title":"IL-1\u03b2, IL-6, TNF- \u03b1 and CRP in elderly patients with depression or Alzheimer\u2019s disease: systematic review and meta-analysis","volume":"8","author":"Ng","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-3-5","article-title":"Interleukin-1 mediates Alzheimer and Lewy body pathologies","volume":"3","author":"Griffin","year":"2006","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.mp.4001809","article-title":"Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer\u2019s disease","volume":"11","author":"Simard","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-016-0088-1","article-title":"The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer\u2019s disease","volume":"11","author":"Saresella","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00005072-199603000-00002","article-title":"Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer\u2019s disease","volume":"55","author":"Mrak","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib35","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1073\/pnas.81.24.7907","article-title":"Nucleotide sequence of human monocyte interleukin 1 precursor cDNA","volume":"81","author":"Auron","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.smim.2013.10.018","article-title":"Interleukin-1\u03b2 in innate inflammation, autophagy and immunity","volume":"25","author":"Joosten","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","article-title":"IL-1, IL-18, and IL-33 families of cytokines","volume":"223","author":"Arend","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib40","doi-asserted-by":"crossref","first-page":"26595","DOI":"10.1074\/jbc.272.42.26595","article-title":"Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells","volume":"272","author":"Akita","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nri1997","article-title":"Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation","volume":"7","author":"Mariathasan","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib42","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molmed.2011.01.005","article-title":"Disease-associated amyloid and misfolded protein aggregates activate the inflammasome","volume":"17","author":"Masters","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.348","article-title":"Amyloid-\u03b2 induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer\u2019s disease","volume":"5","author":"Tan","year":"2014","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib44","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1460-9568.2005.03965.x","article-title":"Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation","volume":"21","author":"Docagne","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4049\/jimmunol.139.2.459","article-title":"Visualization and characterization of interleukin 1 receptors in brain","volume":"139","author":"Farrar","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib46","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1471-4159.2000.740457.x","article-title":"Inflammatory\u201d cytokines: neuromodulators in normal brain?","volume":"74","author":"Vitkovic","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib47","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1074\/jbc.272.12.7727","article-title":"The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)","volume":"272","author":"Wesche","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib48","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4049\/jimmunol.163.2.978","article-title":"Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase","volume":"163","author":"Thomas","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib49","first-page":"3786","article-title":"IL-1R1\/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice","author":"Gasse","year":"2007","journal-title":"J. Clin. Invest. 117"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nri1664","article-title":"Interleukin-1 and neuronal injury","volume":"5","author":"Allan","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12868-022-00699-8","article-title":"Increased MYD88 blood transcript in a mouse model of Alzheimer\u2019s disease","volume":"23","author":"Cucos","year":"2022","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib52","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/343336a0","article-title":"Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor","volume":"343","author":"Hannum","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib53","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/756357","article-title":"A review: inflammatory process in Alzheimer\u2019s disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib54","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.cyto.2014.10.032","article-title":"ADAM17 regulates IL-1 signaling by selectively releasing IL-1 receptor type 2 from the cell surface","volume":"71","author":"Uchikawa","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib55","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1126\/science.8332913","article-title":"Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4","volume":"261","author":"Colotta","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2012.11.006","article-title":"IL-1 receptor 2 (IL-1R2) and its role in immune regulation","volume":"32","author":"Peters","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib57","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1074\/jbc.M803108200","article-title":"Interleukin-1 Receptor Type 1 Is a Substrate for \u03b3-Secretase-dependent Regulated Intramembrane Proteolysis","volume":"284","author":"Elzinga","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib58","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1042\/BST20221445","article-title":"\u03b3-Secretase fanning the fire of innate immunity","volume":"51","author":"Liu","year":"2023","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib59","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.275.5297.206","article-title":"Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme","volume":"275","author":"Gu","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib60","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1126\/science.7535475","article-title":"Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme","volume":"267","author":"Kuida","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib61","first-page":"77","article-title":"Probing the role of interleukin-1 beta convertase in interleukin-1 beta secretion","volume":"35","author":"Howard","year":"1991","journal-title":"Agents Actions Suppl."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib62","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1002\/art.24961","article-title":"Multiple interleukin-1beta-converting enzymes contribute to inflammatory arthritis","volume":"60","author":"Stehlik","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib63","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1002\/art.24959","article-title":"Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation","volume":"60","author":"Guma","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib64","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1073\/pnas.96.11.6261","article-title":"Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3","volume":"96","author":"Coeshott","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib65","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1007\/s11064-015-1714-y","article-title":"Proteinase 3 Induces Neuronal Cell Death Through Microglial Activation","volume":"40","author":"Cho","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2013.05.060","article-title":"Proteinase 3 induces oxidative stress-mediated neuronal death in rat primary cortical neuron","volume":"548","author":"Kwon","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib67","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.bbagen.2014.03.007","article-title":"Matrix metalloproteinases in inflammation","volume":"1840","author":"Nissinen","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib68","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2174\/1389557516666160321112512","article-title":"Caspase-1-independent Maturation of IL-1\u03b2 in Ischemic Brain Injury: is there a Role for Gelatinases?","volume":"16","author":"Amantea","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib69","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.4049\/jimmunol.161.7.3340","article-title":"Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing","volume":"161","author":"Sch\u00f6nbeck","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib70","doi-asserted-by":"crossref","first-page":"14657","DOI":"10.1074\/jbc.271.25.14657","article-title":"Degradation of interleukin 1beta by matrix metalloproteinases","volume":"271","author":"Ito","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib71","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ceb.2009.06.006","article-title":"Matrix metalloproteinase proteomics: substrates, targets, and therapy","volume":"21","author":"Morrison","year":"2009","journal-title":"Curr. Opin. Cell. Biol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib72","doi-asserted-by":"crossref","first-page":"16451","DOI":"10.1073\/pnas.0908507106","article-title":"Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation","volume":"106","author":"Folgueras","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00018-015-1992-1","article-title":"MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer\u2019s disease","volume":"73","author":"Baranger","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib74","first-page":"163","article-title":"MT5-MMP Promotes Alzheimer\u2019s Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro","volume":"9","author":"Baranger","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12974-022-02407-z","article-title":"MT5-MMP promotes neuroinflammation, neuronal excitability and A\u03b2 production in primary neuron\/astrocyte cultures from the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"19","author":"Pilat","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib76","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3390\/biom14121645","article-title":"Suppression of MT5-MMP Reveals Early Modulation of Alzheimer\u2019s Pathogenic Events in Primary Neuronal Cultures of 5xFAD Mice","volume":"14","author":"Pilat","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib77","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0959-437X(02)00334-9","article-title":"M. Freeman, Intramembrane proteolysis controls diverse signalling pathways throughout evolution","volume":"12","author":"Urban","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib78","doi-asserted-by":"crossref","first-page":"11982","DOI":"10.1074\/jbc.M700356200","article-title":"Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase","volume":"282","author":"Kuhn","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib79","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bbrc.2009.02.051","article-title":"TRAF6 promotes ubiquitination and regulated intramembrane proteolysis of IL-1R1","volume":"381","author":"Twomey","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib80","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1042\/BST20170002","article-title":"Regulated intramembrane proteolysis: emergent role in cell signalling pathways","volume":"45","author":"McCarthy","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib81","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.semcdb.2020.05.019","article-title":"The substrate repertoire of \u03b3-secretase\/presenilin","volume":"105","author":"G\u00fcner","year":"2020","journal-title":"Semin. Cell. Dev. Biol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib82","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","article-title":"The inflammasome NLRs in immunity, inflammation, and associated diseases","volume":"29","author":"Davis","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib83","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib84","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1096\/fj.201900439","article-title":"Inflammasome-mediated innate immunity in Alzheimer\u2019s disease","volume":"33","author":"Venegas","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib85","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coi.2017.10.011","article-title":"Recent advances in inflammasome biology","volume":"50","author":"Place","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib86","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-5-7","article-title":"The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective","volume":"5","author":"Shaftel","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib88","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jneuroim.2003.11.001","article-title":"Intraparenchymal administration of interleukin-1beta induces cyclooxygenase-2-mediated expression of membrane- and cytosolic-associated prostaglandin E synthases in mouse brain","volume":"148","author":"Moore","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib89","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1172\/JCI31450","article-title":"Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology","volume":"117","author":"Shaftel","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib90","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0306-4522(02)00048-9","article-title":"Intracerebroventricular but not intravenous interleukin-1beta induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation","volume":"112","author":"Proescholdt","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib91","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1523\/JNEUROSCI.22-14-06071.2002","article-title":"The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury","volume":"22","author":"Basu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib92","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-3-15","article-title":"Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury","volume":"3","author":"Lin","year":"2006","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib93","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneuroim.2005.07.009","article-title":"Differential effects of interleukin-1beta on neurotoxicity, cytokine induction and glial reaction in specific brain regions","volume":"168","author":"Depino","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib94","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib95","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.3892\/mmr.2015.3183","article-title":"Exploring the association between interleukin-1\u03b2 and its interacting proteins in Alzheimer\u2019s disease","volume":"11","author":"Xie","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib96","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3233\/JAD-200056","article-title":"IL-1\u03b2, IL-6, IL-10, and TNF\u03b1 single nucleotide polymorphisms in human influence the susceptibility to alzheimer\u2019s disease pathology","volume":"75","author":"Babi\u0107 Leko","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib97","first-page":"141","article-title":"Brain interleukin-1 beta in Alzheimer\u2019s disease and vascular dementia","volume":"16","author":"Cacabelos","year":"1994","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004010050664","article-title":"Neuritic plaque evolution in Alzheimer\u2019s disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms","volume":"94","author":"Sheng","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib99","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbi.2015.03.006","article-title":"Cytokine-producing microglia have an altered beta-amyloid load in aged APP\/PS1 Tg mice","volume":"48","author":"Babcock","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fnagi.2014.00247","article-title":"Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer\u2019s disease: evidence for a pro-amyloidogenic role of MT1-MMP","volume":"6","author":"Py","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib101","doi-asserted-by":"crossref","first-page":"10075","DOI":"10.1073\/pnas.89.21.10075","article-title":"Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta\/A4 amyloid protein precursor","volume":"89","author":"Buxbaum","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib102","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1074\/jbc.274.10.6421","article-title":"Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5\u2019-untranslated region sequences","volume":"274","author":"Rogers","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib103","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1742-2094-10-59","article-title":"Acute and subacute IL-1\u03b2 administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for neuroprotection and neurodegeneration","volume":"10","author":"Song","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib104","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","article-title":"Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal \u03b2-catenin pathway function in an Alzheimer\u2019s disease model","volume":"187","author":"Kitazawa","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-2-15","article-title":"Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloid","volume":"2","author":"Craft","year":"2005","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib106","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0197-4580(96)00104-2","article-title":"vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis","volume":"17","author":"Sheng","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib107","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2936","article-title":"Emerging inflammasome effector mechanisms","volume":"11","author":"Lamkanfi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib108","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neurobiolaging.2004.05.010","article-title":"Glia and their cytokines in progression of neurodegeneration","volume":"26","author":"Mrak","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib109","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1471-4159.2007.05127.x","article-title":"Interleukin-1 beta up-regulates TACE to enhance alpha-cleavage of APP in neurons: resulting decrease in Abeta production","volume":"104","author":"Tachida","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/OPTH.S2684","article-title":"L.-S. Jen, Differential effects of interleukin-1beta and S100B on amyloid precursor protein in rat retinal neurons","author":"Anderson","year":"2009","journal-title":"Clin. Ophthalmol. 3"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib111","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/jnr.20515","article-title":"Short-term interleukin-1(beta) increases the release of secreted APP(alpha) via MEK1\/2-dependent and JNK-dependent alpha-secretase cleavage in neuroglioma U251 cells","volume":"80","author":"Ma","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib112","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12974-015-0411-8","article-title":"Arginase 1+ microglia reduce A\u03b2 plaque deposition during IL-1\u03b2-dependent neuroinflammation","volume":"12","author":"Cherry","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib113","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","article-title":"M.K. O\u2019Banion, Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model","volume":"33","author":"Ghosh","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib114","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1742-2094-3-17","article-title":"Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy","volume":"3","author":"Das","year":"2006","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2019.11.020","article-title":"IL-1R-\/- alleviates cognitive deficits through microglial M2 polarization in AD mice","volume":"157","author":"Wang","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib116","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.3390\/ijms23168972","article-title":"The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer\u2019s Disease","volume":"23","author":"Sun","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.543331","article-title":"IL-1\u03b2 Induced Cytokine Expression by Spinal Astrocytes Can Play a Role in the Maintenance of Chronic Inflammatory Pain","volume":"11","author":"Gajtk\u00f3","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib118","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0197-4580(01)00287-1","article-title":"W.S. Griffin, Interleukin-1, neuroinflammation, and Alzheimer\u2019s disease","volume":"22","author":"Mrak","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib119","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-b","volume":"9","author":"Halle","year":"2008","journal-title":"eta Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib120","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0197-4580(01)00311-6","article-title":"Modeling microglial activation in Alzheimer\u2019s disease with human postmortem microglial cultures","volume":"22","author":"Lue","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib121","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s12035-017-0467-9","article-title":"NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer\u2019s Disease","volume":"55","author":"Yin","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib122","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1604032113","article-title":"IL-33 ameliorates Alzheimer\u2019s disease-like pathology and cognitive decline","volume":"113","author":"Fu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib123","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20151948","article-title":"TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques","volume":"213","author":"Wang","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib124","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11481-011-9331-2","article-title":"Chronic IL-1\u03b2-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer\u2019s disease without inducing overt neurodegeneration","volume":"7","author":"Matousek","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib125","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1074\/jbc.275.11.7918","volume":"275","author":"Akama","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib126","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/alz.12341","article-title":"Acute systemic inflammation exacerbates neuroinflammation in Alzheimer\u2019s disease: IL-1\u03b2 drives amplified responses in primed astrocytes and neuronal network dysfunction","volume":"17","author":"Lopez-Rodriguez","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib127","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0197-4580(02)00029-5","article-title":"The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau","volume":"23","author":"Hartzler","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib128","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0197-0186(01)00041-9","article-title":"Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer\u2019s disease: potential significance for tau protein phosphorylation","volume":"39","author":"Sheng","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","article-title":"Regulation of tau pathology by the microglial fractalkine receptor","volume":"68","author":"Bhaskar","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","article-title":"Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway","volume":"23","author":"Li","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib131","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4161\/cib.19548","article-title":"Cytoplasmic superoxide radical: a possible contributing factor to intracellular A\u03b2 oligomerization in Alzheimer disease","volume":"5","author":"Murakami","year":"2012","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib132","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jneuroim.2008.09.012","article-title":"Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells","volume":"205","author":"Ojala","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib133","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","article-title":"Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway","volume":"295","author":"Quintanilla","year":"2004","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib134","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1006\/exnr.2000.7393","article-title":"Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo","volume":"163","author":"Sheng","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib135","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3389\/fneur.2020.00929","article-title":"Interleukin-1\u03b2 Drives Cellular Senescence of Rat Astrocytes Induced by Oligomerized Amyloid \u03b2 Peptide and Oxidative Stress","volume":"11","author":"Shang","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib136","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3390\/ijms23041989","article-title":"Aging, Cellular Senescence, and Alzheimer\u2019s Disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib137","article-title":"NLRP3 inflammasome in Alzheimer\u2019s disease: molecular mechanisms and emerging therapies","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib138","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1623","article-title":"Tau induces inflammasome activation and microgliosis through acetylating NLRP3","volume":"14","author":"Zhang","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib139","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/s41467-022-29552-6","article-title":"Microglial NF-\u03baB drives tau spreading and toxicity in a mouse model of tauopathy","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13578-024-01223-7","article-title":"Complement C1q-mediated microglial synaptic elimination by enhancing desialylation underlies sevoflurane-induced developmental neurotoxicity","volume":"14","author":"Wang","year":"2024","journal-title":"Cell. Biosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib141","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq7806","article-title":"Microglia mediate neurocognitive deficits by eliminating C1q-tagged synapses in sepsis-associated encephalopathy","volume":"9","author":"Chung","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib142","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s43587-022-00281-1","article-title":"Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer\u2019s disease mouse models","volume":"2","author":"Dejanovic","year":"2022","journal-title":"Nat. Aging"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib143","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40478-019-0754-y","article-title":"Intersection of pathological tau and microglia at the synapse","volume":"7","author":"Vogels","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib144","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1038\/s41467-025-59849-1","article-title":"Targeting C1q prevents microglia-mediated synaptic removal in neuropathic pain","volume":"16","author":"Yousefpour","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib145","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1111\/bph.14618","article-title":"Microglial inflammation and phagocytosis in Alzheimer\u2019s disease: Potential therapeutic targets","volume":"176","author":"Nizami","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib146","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12974-019-1694-y","article-title":"Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia","volume":"17","author":"Das","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib147","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s44400-025-00011-5","article-title":"Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegeneration","volume":"1","author":"Auger","year":"2025","journal-title":"Npj Dement."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101208","article-title":"Synaptic basis of Alzheimer\u2019s disease: focus on synaptic amyloid beta, P-tau and mitochondria","volume":"65","author":"John","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib149","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.brainres.2014.08.040","article-title":"Neuroinflammatory changes negatively impact on LTP: A focus on IL-1\u03b2","volume":"1621","author":"Lynch","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib151","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1523\/JNEUROSCI.5712-03.2004","article-title":"Cell type-specific interleukin-1beta signaling in the CNS","volume":"24","author":"Srinivasan","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib152","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0166-4328(02)00043-8","article-title":"Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus","volume":"134","author":"Barrientos","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib153","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/brbi.1995.1012","article-title":"Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-b","volume":"9","author":"Gibertini","year":"1995","journal-title":"eta Brain Behav. Immun."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib154","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0006-8993(93)90468-3","article-title":"Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning","volume":"613","author":"Oitzl","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbi.2009.10.002","article-title":"Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice","volume":"24","author":"Hein","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib156","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.neurobiolaging.2005.03.010","article-title":"Peripheral infection and aging interact to impair hippocampal memory consolidation","volume":"27","author":"Barrientos","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib157","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbi.2007.08.014","article-title":"Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system","volume":"22","author":"Chen","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib158","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbi.2008.07.002","article-title":"Time course of hippocampal IL-1 beta and memory consolidation impairments in aging rats following peripheral infection","volume":"23","author":"Barrientos","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib159","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbi.2009.07.008","article-title":"Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide","volume":"24","author":"Frank","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib160","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.psyneuen.2007.09.004","article-title":"A dual role for interleukin-1 in hippocampal-dependent memory processes","volume":"32","author":"Goshen","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib161","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hipo.10164","article-title":"Learning modulation by endogenous hippocampal IL-1: blockade of endogenous IL-1 facilitates memory formation","volume":"14","author":"Depino","year":"2004","journal-title":"Hippocampus"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib162","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-8993(93)90959-Q","article-title":"Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus","volume":"628","author":"Bellinger","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib163","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jneuroim.2003.08.030","article-title":"A dual role for interleukin-1 in LTP in mouse hippocampal slices","volume":"144","author":"Ross","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib164","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-2999(90)90099-R","article-title":"Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices","volume":"181","author":"Katsuki","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib165","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1523\/JNEUROSCI.18-08-02974.1998","article-title":"Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation","volume":"18","author":"Murray","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib166","doi-asserted-by":"crossref","first-page":"19453","DOI":"10.1074\/jbc.M301938200","article-title":"Activation of p38 plays a pivotal role in the inhibitory effect of lipopolysaccharide and interleukin-1 beta on long term potentiation in rat dentate gyrus","volume":"278","author":"Kelly","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib167","doi-asserted-by":"crossref","first-page":"18048","DOI":"10.1523\/JNEUROSCI.4067-11.2011","article-title":"Neuron-specific effects of interleukin-1\u03b2 are mediated by a novel isoform of the IL-1 receptor accessory protein","volume":"31","author":"Huang","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib168","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1523\/JNEUROSCI.15-05-03468.1995","article-title":"Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor","volume":"15","author":"Strijbos","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib169","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20161673","article-title":"Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations","volume":"214","author":"Bading","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fnmol.2018.00307","article-title":"Neurotoxic agent-induced injury in neurodegenerative disease model: focus on involvement of glutamate receptors","volume":"11","author":"Jakaria","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib171","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.4049\/jimmunol.163.7.3963","article-title":"Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways","volume":"163","author":"Carlson","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib172","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1471-4159.2006.03872.x","article-title":"Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release","volume":"98","author":"Thornton","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib173","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.637703","article-title":"Interleukin-1\u03b2 modulates synaptic transmission and synaptic plasticity during the acute phase of sepsis in the senescence-accelerated mouse hippocampus","volume":"13","author":"Hoshino","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib174","doi-asserted-by":"crossref","first-page":"17714","DOI":"10.1523\/JNEUROSCI.1253-12.2012","article-title":"Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1\u03b2 via p38 mitogen-activated protein kinase","volume":"32","author":"Tong","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib175","doi-asserted-by":"crossref","first-page":"9301","DOI":"10.1523\/JNEUROSCI.1418-07.2007","article-title":"Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration","volume":"27","author":"Shaftel","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib176","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2006.06.013","article-title":"Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra","volume":"24","author":"Ferrari","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib177","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00702-004-0222-z","article-title":"Intra-parenchymal injection of tumor necrosis factor-alpha and interleukin 1-beta produces dopamine neuron loss in the rat","volume":"112","author":"Carvey","year":"2005","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib178","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer\u2019s disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib179","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12017-025-08866-w","article-title":"Inflammatory markers and their relationship with cognitive function in alzheimer\u2019s disease and mild cognitive impairment. Systematic review and meta-analysis","volume":"27","author":"Serna","year":"2025","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib180","article-title":"Cerebrospinal fluid cytokine levels affect electroencephalographic activity in Alzheimer\u2019s disease","volume":"9","author":"Bruno","year":"2025","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib181","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","article-title":"Brain interleukin 1 and S-100 immunoreactivity are elevated in down syndrome and Alzheimer disease","volume":"86","author":"Griffin","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib182","doi-asserted-by":"crossref","first-page":"11","DOI":"10.30773\/pi.2020.0205","article-title":"The Association of Blood-Based Inflammatory Factors IL-1\u03b2, TGF-\u03b2 and CRP with Cognitive Function in Alzheimer\u2019s Disease and Mild Cognitive Impairment","volume":"18","author":"Park","year":"2021","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib183","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.85377","article-title":"A Systematic Review of the Efficacy and Safety of Anti-amyloid Monoclonal Antibodies in Alzheimer\u2019s Disease","author":"Chundu","year":"2025","journal-title":"Cureus 17"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib184","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-141506","article-title":"Anti-inflammatory drugs and risk of Alzheimer\u2019s disease: an updated systematic review and meta-analysis","volume":"44","author":"Wang","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib185","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","article-title":"Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice","volume":"61","author":"Dempsey","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib186","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13075-018-1664-2","article-title":"NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis","volume":"20","author":"Marchetti","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib187","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2026.07.004_bib188","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","article-title":"Tranilast: a review of its therapeutic applications","volume":"91","author":"Darakhshan","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib189","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib190","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.cytogfr.2026.07.004_bib191","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2018.11.010","article-title":"Inhibitors of NF-\u03baB and P2X7\/NLRP3\/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer\u2019s disease","volume":"326","author":"Thawkar","year":"2019","journal-title":"J. Neuroimmunol."}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:32:40Z","timestamp":1788881560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610126000560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":191,"alternative-id":["S1359610126000560"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.07.004","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multifaceted roles of IL-1\u03b2 in Alzheimer\u2019s disease: From pathogenic amplifier to neuroimmune modulator","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}